Synopsis
Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Rifomycin S
2. Rifampicin S
| Molecular Weight | 822.9 g/mol |
|---|---|
| Molecular Formula | C43H58N4O12 |
| XLogP3 | 4 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 5 |
| Exact Mass | 822.40512330 g/mol |
| Monoisotopic Mass | 822.40512330 g/mol |
| Topological Polar Surface Area | 217 A^2 |
| Heavy Atom Count | 59 |
| Formal Charge | 0 |
| Complexity | 1750 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 4 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 6 | |
|---|---|
| Drug Name | Rifadin |
| PubMed Health | Rifampin (Injection) |
| Drug Classes | Antitubercular |
| Drug Label | RIFADIN (rifampin capsules USP) for oral administration contain 150 mg or 300 mg rifampin per capsule. The 150 mg and 300 mg capsules also contain, as inactive ingredients: corn starch, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin |
| Active Ingredient | Rifampin |
| Dosage Form | Capsule; Injectable |
| Route | Injection; Oral |
| Strength | 150mg; 300mg; 600mg/vial |
| Market Status | Prescription |
| Company | Sanofi Aventis Us |
| 2 of 6 | |
|---|---|
| Drug Name | Rifampin |
| Active Ingredient | Rifampin |
| Dosage Form | Capsule; Injectable |
| Route | Injection; Oral |
| Strength | 150mg; 300mg; 600mg/vial |
| Market Status | Prescription |
| Company | Bedford; Lupin Pharms; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Versapharm; Lannett; Agila Speclts |
| 3 of 6 | |
|---|---|
| Drug Name | Rimactane |
| PubMed Health | Rifampin |
| Drug Classes | Antitubercular |
| Drug Label | Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin is a red-brown crystalline powder very slightly soluble in water at neutral pH, freely soluble in chloroform, soluble in ethyl acetate and in methanol. Its molecular weight i... |
| Active Ingredient | Rifampin |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 300mg |
| Market Status | Prescription |
| Company | Prosam Labs |
| 4 of 6 | |
|---|---|
| Drug Name | Rifadin |
| PubMed Health | Rifampin (Injection) |
| Drug Classes | Antitubercular |
| Drug Label | RIFADIN (rifampin capsules USP) for oral administration contain 150 mg or 300 mg rifampin per capsule. The 150 mg and 300 mg capsules also contain, as inactive ingredients: corn starch, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin |
| Active Ingredient | Rifampin |
| Dosage Form | Capsule; Injectable |
| Route | Injection; Oral |
| Strength | 150mg; 300mg; 600mg/vial |
| Market Status | Prescription |
| Company | Sanofi Aventis Us |
| 5 of 6 | |
|---|---|
| Drug Name | Rifampin |
| Active Ingredient | Rifampin |
| Dosage Form | Capsule; Injectable |
| Route | Injection; Oral |
| Strength | 150mg; 300mg; 600mg/vial |
| Market Status | Prescription |
| Company | Bedford; Lupin Pharms; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Versapharm; Lannett; Agila Speclts |
| 6 of 6 | |
|---|---|
| Drug Name | Rimactane |
| PubMed Health | Rifampin |
| Drug Classes | Antitubercular |
| Drug Label | Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin is a red-brown crystalline powder very slightly soluble in water at neutral pH, freely soluble in chloroform, soluble in ethyl acetate and in methanol. Its molecular weight i... |
| Active Ingredient | Rifampin |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 300mg |
| Market Status | Prescription |
| Company | Prosam Labs |

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Rifadin
Dosage Form : Rifampicin 2% 60Ml Oral Use
Dosage Strength : 1 bottle 60 ml 20 mg/ml syrup
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Rifadin
Dosage Form : Rifampicin 450Mg 8 Joined' Oral Use
Dosage Strength : 8 cpr riv 450 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Rifadin
Dosage Form : Rifampicin 600Mg 1 Unit Parenteral Use
Dosage Strength : 1 ampoule EV 600 mg + 1 ampoule solv 10 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Rifinah
Dosage Form : Coated Tablet
Dosage Strength :
Packaging :
Approval Date : 18/09/1975
Application Number : 38931
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Rifinah
Dosage Form : Film Coated Tablet
Dosage Strength : 150MG; 300MG
Packaging :
Approval Date : 2007-08-08
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Rifinah
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG; 150MG
Packaging :
Approval Date : 2011-03-14
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Isoniazide; Pyrazinamide; Rifampicin
Brand Name : Rifater Coated Tablets
Dosage Form : Film Coated Tablet
Dosage Strength :
Packaging :
Approval Date : 01-04-1989
Application Number : 58299
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rifinah
Dosage Form : Film Coated Tablet
Dosage Strength : 300MG; 150 MG
Packaging :
Approval Date : 01-09-1978
Application Number : 54213
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rifaldin
Dosage Form : Capsule
Dosage Strength : 300MG
Packaging :
Approval Date : 01-06-1968
Application Number : 46029
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Rifaldin
Dosage Form : Powder And Solvent For Infusion Solution
Dosage Strength : 600MG
Packaging :
Approval Date : 01-03-1986
Application Number : 56487
Regulatory Info : Authorized
Registration Country : Spain
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Thickeners and Stabilizers
Excipient Details : Used as carbon source in cell cultures in upstream, cryoprotectant and stabilizer in lyophilized formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Saccharose Excipient
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Solution, Tablet
Grade : Topical, Oral
Category : API Stability Enhancers, Emulsifying Agents, Fillers, Diluents & Binders
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Application : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-175 µm, Tapped Density: 0.85
Ingredient(s) : Calcium Carbonate Excipient
Application : Fillers, Diluents & Binders
Excipient Details : KoVidone® K25 is used as a low viscosity wet binder in solid dosage forms such as capsules and tablets.
Brand Name : Lactose Monohydrate
Application : Parenteral
Excipient Details : Lactose monohydrate is used as a diluent in inhalation and lyophilized preparations.
Brand Name : Magnesium Carbonate
Application : Fillers, Diluents & Binders
Excipient Details : Magnesium Carbonate is a pharmaceutical excipient which is used a a whitening agent in oral solid dosage forms such as tablets.
Pharmacopoeia Ref : Ph. Eur.|USP
Technical Specs : Not Available
Ingredient(s) : Magnesium Carbonate Excipient
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Suspension, Tablet
Grade : Topical, Oral
Category : Coating Systems & Additives, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Thickeners and Stabilizers
Brand Name : Carboxymethyl Cellulose
Application : Coating Systems & Additives, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Thickeners and Stabilizers
Excipient Details : Carboxymethylcellulose serves as a disintegrant, binder, coating agent & thickener in oral formulations, also as a stabilizer in topical formulations.
Grade : Oral
Category : Co-Processed Excipients, Fillers, Diluents & Binders
Application : Co-Processed Excipients, Fillers, Diluents & Binders
Excipient Details : ProBlend (SMCC) is a co-processed excipient consists of microcrystalline cellulose & colloidal silicon dioxide, used as a diluent & binder in OSDs.
Pharmacopoeia Ref : USP-NF,BP,EP,IP
Technical Specs : NA
Ingredient(s) : Microcrystalline Cellulose Excipients
Application : Co-Processed Excipients, Fillers, Diluents & Binders
Excipient Details : Microlose (Lactose Monohydrate & Microcrystalline Cellulose) is used as a diluent in oral dosage forms such as tablets.
Pharmacopoeia Ref : USP-NF,BP,EP,IP
Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%
Ingredient(s) : Lactose Monohydrate
Dosage Form : Capsule, Injectable / Parenteral, Tablet
Grade : Oral, Parenteral
Category : Fillers, Diluents & Binders, Parenteral
https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
Global Sales Information
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Isoniazid; Pyrazinamide; Rifampicin
Dosage Form : Isoniazid+Pyrazinamide+Rifampici...
Dosage Strength : 40 cpr riv 50 mg + 300mg + 120 mg
Price Per Pack (Euro) : 10.57
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Rifampicin 2% 60Ml Oral Use
Dosage Strength : 1 bottle 60 ml 20 mg/ml syrup
Price Per Pack (Euro) : 2.8
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Rifampicin 300Mg 8 Joined' Oral ...
Dosage Strength : 8 cps 300 mg
Price Per Pack (Euro) : 3.72
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Rifampicin 450Mg 8 Joined' Oral ...
Dosage Strength : 8 cpr riv 450 mg
Price Per Pack (Euro) : 4.86
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Rifampicin 600Mg 1 Unit Parenter...
Dosage Strength : 1 ampoule EV 600 mg + 1 ampoule solv 10 ml
Price Per Pack (Euro) : 9.28
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class A
Dosage Form : Rifampicin+Isoniazid+150300 Mg 2...
Dosage Strength : 24 cpr riv 300 mg + 150 mg
Price Per Pack (Euro) : 9.48
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Dosage Form : CAPSULE;ORAL
Dosage Strength : 150MG
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX

Dosage Form : CAPSULE;ORAL
Dosage Strength : 300MG
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX

Dosage Form : CAPSULE;ORAL
Dosage Strength : 300MG
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX

Dosage Form : CAPSULE;ORAL
Dosage Strength : 150MG
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
96
PharmaCompass offers a list of Rifampicin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rifampicin manufacturer or Rifampicin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rifampicin manufacturer or Rifampicin supplier.
PharmaCompass also assists you with knowing the Rifampicin API Price utilized in the formulation of products. Rifampicin API Price is not always fixed or binding as the Rifampicin Price is obtained through a variety of data sources. The Rifampicin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Riforal manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Riforal, including repackagers and relabelers. The FDA regulates Riforal manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Riforal API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Riforal manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Riforal supplier is an individual or a company that provides Riforal active pharmaceutical ingredient (API) or Riforal finished formulations upon request. The Riforal suppliers may include Riforal API manufacturers, exporters, distributors and traders.
click here to find a list of Riforal suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Riforal DMF (Drug Master File) is a document detailing the whole manufacturing process of Riforal active pharmaceutical ingredient (API) in detail. Different forms of Riforal DMFs exist exist since differing nations have different regulations, such as Riforal USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Riforal DMF submitted to regulatory agencies in the US is known as a USDMF. Riforal USDMF includes data on Riforal's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Riforal USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Riforal suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Riforal Drug Master File in Japan (Riforal JDMF) empowers Riforal API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Riforal JDMF during the approval evaluation for pharmaceutical products. At the time of Riforal JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Riforal suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Riforal Drug Master File in Korea (Riforal KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Riforal. The MFDS reviews the Riforal KDMF as part of the drug registration process and uses the information provided in the Riforal KDMF to evaluate the safety and efficacy of the drug.
After submitting a Riforal KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Riforal API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Riforal suppliers with KDMF on PharmaCompass.
A Riforal CEP of the European Pharmacopoeia monograph is often referred to as a Riforal Certificate of Suitability (COS). The purpose of a Riforal CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Riforal EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Riforal to their clients by showing that a Riforal CEP has been issued for it. The manufacturer submits a Riforal CEP (COS) as part of the market authorization procedure, and it takes on the role of a Riforal CEP holder for the record. Additionally, the data presented in the Riforal CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Riforal DMF.
A Riforal CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Riforal CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Riforal suppliers with CEP (COS) on PharmaCompass.
A Riforal written confirmation (Riforal WC) is an official document issued by a regulatory agency to a Riforal manufacturer, verifying that the manufacturing facility of a Riforal active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Riforal APIs or Riforal finished pharmaceutical products to another nation, regulatory agencies frequently require a Riforal WC (written confirmation) as part of the regulatory process.
click here to find a list of Riforal suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Riforal as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Riforal API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Riforal as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Riforal and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Riforal NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Riforal suppliers with NDC on PharmaCompass.
Riforal Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Riforal GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Riforal GMP manufacturer or Riforal GMP API supplier for your needs.
A Riforal CoA (Certificate of Analysis) is a formal document that attests to Riforal's compliance with Riforal specifications and serves as a tool for batch-level quality control.
Riforal CoA mostly includes findings from lab analyses of a specific batch. For each Riforal CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Riforal may be tested according to a variety of international standards, such as European Pharmacopoeia (Riforal EP), Riforal JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Riforal USP).